Pospisilik
Laboratory
Epigenetic Origins of Heterogeneity and Disease
Diabetes, neurodegenerative diseases, cancer and obesity are among the world’s most pressing public health challenges, affecting more than 1 billion people. Although vastly different on the surface, these diverse conditions are now thought to stem, at least partially, from alterations in the epigenetic mechanisms that regulate gene expression and metabolism. Recent evidence suggests that genetic predisposition, early life environment and even intergenerational influences prior to birth can have lasting consequences for health across the lifespan.
The Pospisilik Lab seeks to better understand epigenetic regulatory systems and their role in disease susceptibility and heterogeneity. Beyond advancing understanding of individual biological variation, the lab’s goal is to translate our findings into improved approaches for disease prediction, prevention, diagnosis and therapy. Ultimately, we hope to develop new tools that leverage epigenetic health states to predict a person’s lifelong health trajectory at birth.
Earlier work by Dr. Pospisilik and the team have resulted in a series of major advances in the field, including elucidation of some of the first molecular pathways that define healthy versus unhealthy obesity; the identification of the first disease-causing epigenetic defects in diabetes; and the development of foundational models of purely epigenetic disease.
Our Impact
We’re raising thousands to save millions.
We’re turning hope into action for the millions of people around the world affected by diseases like cancer and Parkinson’s. Find out how you can help us make a difference.
- 141 peer-reviewed papers published in 2025, 74 of which were in high-impact journals
- 15 VAI-SU2C Epigenetics Dream Team clinical trials launched to date
- 10 clinical trials and related projects supported by VAI through the International Linked Clinical Trials Program
J. Andrew Pospisilik, Ph.D.
Chair and Professor, Department of Epigenetics
Areas of Expertise
Epigenetics, phenotypic variation, metabolism, epigenetic health states, stochasticity, model development, transgenerational effects
Biography
Dr. J. Andrew Pospisilik is a leading expert in the study of how the epigenome regulates complex trait variation as well as disease susceptibility and heterogeneity. He earned his B.Sc. with honors and his Ph.D. in Physiology from University of British Columbia, where his work focused on type 1 and 2 diabetes. Later, as a postdoctoral fellow in the lab of Dr. Josef M. Penninger at IMBA Institute of Molecular Biotechnology, Dr. Pospisilik performed the first genome-wide RNAi-screen for obesity in Drosophila, identifying some of the first specific developmental regulators of brown adipose tissue formation, and overturned dogma showing that compromised mitochondrial function actually buffers against diabetes. In 2010, he established his laboratory at Max Planck Institute of Immunobiology and Epigenetics in Freiburg, Germany, where his team made groundbreaking advances, including development of novel sensitized models for understanding epigenetic stability and variation in metabolic disease; the first formal proof for the existence of polyphenism in mammals (including suggestions in humans) and the first mapping of a genetic architecture for mammalian phenotypic buffering. In 2018, Dr. Pospisilik joined Van Andel Institute as chair of its Department of Epigenetics and a founding member of its Metabolic and Nutritional Programming group. He is the recipient of numerous awards and accolades, including the 2016 Novo Nordisk Helmholtz Young Investigator Award, the 2015 GSK Award for Basic Medical Research, the 2013 EASD Rising Star Award and the 2011 RISE1 Award from the Epigenesys Network of Excellence. He also is a member of the World Economic Forum faculty.
Leah Bishop
Research Data Technician, Department of Epigenetics
Holly Dykstra, MPH
Research Associate, Department of Epigenetics
Brooke Grimaldi, Ph.D.
Postdoctoral Fellow, Pospisilik Laboratory
Josef Gullmets, Ph.D.
Postdoctoral Fellow, Pospisilik Laboratory
Justin Kulchycki, M.S.
Ph.D. Student, VAI Graduate School
Research Focus: Decoding genetic and environmental interplay in the developmental programming of metabolic phenotypes
Mitch McDonald
Ph.D. Student, VAI Graduate School
Research Focus: Characterizing the probabilistic inheritance of non-genetic obesity in a mouse model of Neuronatin deficiency
Thomas O'Haren, Ph.D.
Postdoctoral Fellow, Lempradl Laboratory & Pospisilik Laboratory
Andrea Parham, M.S., Ph.D.
Research Associate, Department of Epigenetics
Kathy Ryktarsyk
Senior Administrative Assistant II, Department of Epigenetics
Robert Vaughan, Ph.D.
Scientific Project Leader I, Department of Epigenetics
Epigenetic Origins of Heterogeneity and Disease